Back
Theriva Biologics Stock Price Chart
Sponsored
TOVX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
TOVX
Theriva Biologics
Last Price:
1.24
Seasonality Move:
98.81%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.4 | Sell |
20-day SMA: | 1.61 | Sell |
50-day SMA: | 2.03 | Sell |
200-day SMA: | 6.83 | Sell |
8-day EMA: | 1.4 | Sell |
20-day EMA: | 1.58 | Sell |
50-day EMA: | 2.21 | Sell |
200-day EMA: | 6.25 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 35.64 | Sell |
Chaikin Money Flow: | -40489 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.32 - 1.86) | Sell |
Bollinger Bands (100): | (1.67 - 5.69) | Sell |
Theriva Biologics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.26 while TOVX 8-day simple moving average is 1.40, which is a Sell signal.
- The stock price of TOVX is 1.26 while Theriva Biologics 20-day SMA is 1.61, which makes it a Sell.
- Theriva Biologics 50-day simple moving average is 2.03 while TOVX share price is 1.26, making it a Sell technically.
- TOVX stock price is 1.26 and Theriva Biologics 200-day simple moving average is 6.83, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
42
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Sell
The current Theriva Biologics [TOVX] share price is $1.26. The Score for TOVX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
3.51M
Price in USD:
1.26
Share Volume:
57.4K
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
1.24
Sell
42
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?
The Theriva Biologics stock price is 1.26 USD today. -
Will TOVX stock go up or go down?
Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators -
Is Theriva Biologics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.26 while TOVX 8-day exponential moving average is 1.40, which is a Sell signal.
- The stock price of TOVX is 1.26 while Theriva Biologics 20-day EMA is 1.58, which makes it a Sell.
- Theriva Biologics 50-day exponential moving average is 2.21 while TOVX share price is 1.26, making it a Sell technically.
- TOVX stock price is 1.26 and Theriva Biologics 200-day simple moving average is 6.25, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
- TOVX Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Theriva Biologics is a Sell
- Theriva Biologics Relative Strength Index (RSI) is 35.64, which suggest Theriva Biologics is oversold
- The Bollinger Bands (25) for Theriva Biologics is (1.32 - 1.86), which suggest Theriva Biologics is a Sell
- The Bollinger Bands (100) for Theriva Biologics is (1.67 - 5.69), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.